de Jong Margriet F C, Beishuizen Albertus, Spijkstra Jan-Jaap, Groeneveld A B Johan
Intensive Care and Institute for Cardiovascular Research, Vrije Universiteit Medical Center, Amsterdam, The Netherlands.
Crit Care Med. 2007 Aug;35(8):1896-903. doi: 10.1097/01.CCM.0000275387.51629.ED.
To evaluate the concept of relative adrenal insufficiency necessitating corticosteroid therapy in septic shock.
Retrospective study.
Medical-surgical intensive care unit of a university hospital.
We studied 218 consecutive patients with septic shock in a 3-yr period who underwent a short 250-microg adrenocorticotropic hormone test because of >6 hrs of hypotension requiring repeated fluid challenges and/or vasopressor/inotropic treatment.
The test was performed by intravenously injecting 250 mug of synthetic adrenocorticotropic hormone and measuring cortisol immediately before and 30 and 60 mins postinjection.
Intensive care unit mortality until day 28 was 22%. Nonsurvivors had greater disease severity, as exemplified by higher Simplified Acute Physiology Score II and Sequential Organ Failure Assessment score, on the day of adrenocorticotropic hormone testing. Cortisol levels directly correlated with albumin levels. Simplified Acute Physiology Score II and Sequential Organ Failure Assessment score increased with higher strata of baseline cortisol/albumin or lower cortisol increases/albumin ratios as measures of free cortisol. Baseline cortisol, cortisol increases, and albumin levels did not independently contribute to mortality prediction by disease severity and absence of corticosteroid (hydrocortisone) treatment in a Cox proportional hazard model, although adrenocorticotropic hormone-induced cortisol increase <100 nmol/L (n = 53) predicted mortality (p = .007). Posttest treatment by corticosteroids (n = 161, 74%) was associated with higher survival in patients with cortisol increase <100 nmol/L (p = .0296).
In intensive care unit patients with septic shock, the cortisol response to adrenocorticotropic hormone inversely relates to disease severity, independent of blood cortisol binding. An adrenocorticotropic hormone-induced cortisol increase <100 nmol/L predicts mortality and beneficial effects of corticosteroid treatment. The data favor relative adrenal insufficiency.
评估脓毒性休克中需要皮质类固醇治疗的相对肾上腺功能不全的概念。
回顾性研究。
一所大学医院的内科-外科重症监护病房。
我们研究了3年内连续218例脓毒性休克患者,这些患者因低血压超过6小时需要反复补液和/或血管加压药/正性肌力药治疗而接受了短时间的250微克促肾上腺皮质激素试验。
通过静脉注射250微克合成促肾上腺皮质激素并在注射前、注射后30分钟和60分钟测量皮质醇来进行该试验。
至第28天的重症监护病房死亡率为22%。在促肾上腺皮质激素检测当天,非幸存者的疾病严重程度更高,如简化急性生理学评分II和序贯器官衰竭评估评分更高所示。皮质醇水平与白蛋白水平直接相关。作为游离皮质醇的指标,简化急性生理学评分II和序贯器官衰竭评估评分随着基线皮质醇/白蛋白的更高分层或更低的皮质醇升高/白蛋白比值而增加。在Cox比例风险模型中,基线皮质醇、皮质醇升高和白蛋白水平并不能独立地通过疾病严重程度和未使用皮质类固醇(氢化可的松)治疗来预测死亡率,尽管促肾上腺皮质激素诱导的皮质醇升高<100 nmol/L(n = 53)可预测死亡率(p = 0.007)。皮质类固醇的试验后治疗(n = 161,74%)与皮质醇升高<100 nmol/L的患者更高的生存率相关(p = 0.0296)。
在重症监护病房的脓毒性休克患者中,皮质醇对促肾上腺皮质激素的反应与疾病严重程度呈负相关,与血皮质醇结合无关。促肾上腺皮质激素诱导的皮质醇升高<100 nmol/L可预测死亡率和皮质类固醇治疗的有益效果。这些数据支持相对肾上腺功能不全。